• FAQs
  • Glossary
Close

FAQs

What is gene and cell therapy?
What are ATMPs, and where do they fit into gene and cell therapy?
Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

See full Glossary

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
    Showing 1 of 171 results.
    Page 35 of 35
    2021

    What is Public and Patient Involvement

    Toolkit of resources published by the Alzheimers Society
    Visit this Resource

    Research Field

    • General

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • UK

    Content Type

    • Resource
    Back to top